1,548
Views
0
CrossRef citations to date
0
Altmetric
Editorial

The Role of Nanomedicine in COVID-19 Therapeutics

ORCID Icon
Pages 133-136 | Received 23 Sep 2021, Accepted 17 Nov 2021, Published online: 11 Jan 2022

References

  • Muhammad W, Zhai Z, Gao C. Antiviral activity of nanomaterials against coronaviruses. Macromol. Biosci. 20(10), 1–12 (2020).
  • Ho W, Gao M, Li F, Li Z, Zhang XQ, Xu X. Next-generation vaccines: nanoparticle-mediated DNA and mRNA delivery. Adv. Healthc. Mater. 10(8), 1–17 (2021).
  • Shin MD, Shukla S, Chung YH et al. COVID-19 vaccine development and a potential nanomaterial path forward. Nat. Nanotechnol. 15(8), 646–655 (2020).
  • Iravani S. Nano- and biosensors for the detection of SARS-CoV-2: challenges and opportunities. Mater. Adv. 1(9), 3092–3103 (2020).
  • Udugama B, Kadhiresan P, Kozlowski HN et al. Diagnosing COVID-19: the disease and tools for detection. ACS Nano 14(4), 3822–3835 (2020).
  • Jain S, Nehra M, Kumar R et al. Internet of Medical Things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases. Biosens. Bioelectron. 179, 113074 (2021).
  • Kaushik A. Manipulative magnetic nanomedicine: the future of COVID-19 pandemic/endemic therapy. Expert Opin. Drug Deliv. 18(5), 531–534 (2021).
  • Gazzi A, Fusco L, Orecchioni M et al. Graphene, other carbon nanomaterials and the immune system: toward nanoimmunity-by-design. J. Phys. Mater. 3(3), 034009 (2020).
  • Bonam SR, Kotla NG, Bohara RA, Rochev Y, Webster TJ, Bayry J. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today 36, 101051 (2021).
  • Sharma S, Bhatia V. Nanoscale drug delivery systems for glaucoma: experimental and in silico advances. Curr. Top. Med. Chem. 20, 1–11 (2020).
  • Campos EVR, Pereira AES, De Oliveira JL et al. How can nanotechnology help to combat COVID-19? Opportunities and urgent need. J. Nanobiotechnol. 18(1), 1–23 (2020).
  • Abd Ellah NH, Gad SF, Muhammad K, Batiha EG, Hetta HF. Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine 15(21), 2085–2102 (2020).
  • Wu J, Wang H, Li B. Structure-aided ACEI-capped remdesivir-loaded novel PLGA nanoparticles: toward a computational simulation design for anti-SARS-CoV-2 therapy. Phys. Chem. Chem. Phys. 22(48), 28434–28439 (2020).
  • Chaudhary N, Weissman D, Whitehead KA. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817–838 (2021).
  • Ward BJ, Gobeil P, Séguin A et al. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nat. Med. 27(6), 1071–1078 (2021).
  • Zhang Q, Honko A, Zhou J et al. Cellular nanosponges inhibit SARS-CoV-2 infectivity. Nano Lett. 20(7), 5570–5574 (2020).
  • Al-Hatamleh MAI, Hatmal MM, Alshaer W et al. COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: an overview and future perspectives based on polymersomes. Eur. J. Pharmacol. 896, 173930 (2021).
  • Zhang XY, Zhang PY. Polymersomes in nanomedicine-A review. Current Nanoscience 13(2), 124–129 (2017).
  • Sharma S, Bhatia V. Magnetic nanoparticles in microfluidics-based diagnostics: an appraisal. Nanomedicine 16(15), 1329–1342 (2021).
  • Yousefi Dehbidi M, Goodarzi N, Azhdari MH, Doroudian M. Mesenchymal stem cells and their derived exosomes to combat COVID-19. Rev. Med. Virol. doi: 10.1002/rmv.2281 (2021) ( Epub ahead of print).
  • De Maio F, Palmieri V, Babini G et al. Graphene nanoplatelet and graphene oxide functionalization of face mask materials inhibits infectivity of trapped SARS-CoV-2. iScience 24(7), 102788 (2021).
  • Chanda A. Environment-friendly plant-based edible vaccines – a novel technique to fight SARS-CoV-2 and other pandemics: a review. In: Multidimensional Approaches to Impacts of Changing Environment on Human Health. CRC Press, FL, USA, 307–316 (2021).
  • Thakur N, Shukla SK, Hussain CM. COVID detection via nanotechnology: a promising field in the diagnosis and analysis of novel coronavirus infection. In: Detection and Analysis of SARS Coronavirus. Wiley‐VCH Verlag GmbH, Weinheim, Germany, 57–73 (2021).
  • Bosetti R, Jones SL. Cost–effectiveness of nanomedicine: estimating the real size of nano-costs. Nanomedicine (Lond.) 14(11), 1367–1370 (2019).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.